Lukas Wießner

Psychopharmacologist

Data updated

Papers

9 publications

Trials

0 clinical trials

Research Footprint

Lukas Wießner appears in 9 tracked papers (2021–2025), most studied alongside LSD, DMT and Psilocybin, across Healthy Volunteers, Anxiety Disorders and Depressive Disorders.

Most-cited paper: LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model (52 citations).

Frequent co-authors: Fernanda Palhano-Fontes, Isabel Wießner and Draulio Araújo.

Background & Research

I. Wießner (full given name not available in supplied records) is a researcher active in experimental human psychopharmacology with a specific focus on lysergic acid diethylamide (LSD). Wießner is listed as an author on multiple healthy-volunteer studies and drafts that probe LSD's effects across cognitive domains — including episodic memory, verbal fluency and cognitive flexibility — and on higher-order processes such as creativity, language production and the phenomenology of mystical experiences. The body of work represented in the available records emphasises careful behavioural characterisation of acute drug effects as well as so-called afterglow and hangover phenomena.